Wells Fargo’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$345M Sell
1,762,769
-6,324
-0.4% -$1.23M 0.07% 259
2025
Q4
$307M Sell
1,769,093
-36,201
-2% -$6.59M 0.06% 284
2025
Q3
$344M Sell
1,805,294
-31,153
-2% -$5.53M 0.07% 251
2025
Q2
$330M Buy
1,836,447
+64,117
+4% +$11.1M 0.07% 249
2025
Q1
$300M Buy
1,772,330
+352,924
+25% +$58M 0.07% 258
2024
Q4
$214M Sell
1,419,406
-40,188
-3% -$6.25M 0.05% 314
2024
Q3
$227M Sell
1,459,594
-51,376
-3% -$7.67M 0.05% 301
2024
Q2
$207M Sell
1,510,970
-66,730
-4% -$9.14M 0.05% 298
2024
Q1
$210M Buy
1,577,700
+34,719
+2% +$4.5M 0.05% 297
2023
Q4
$213M Sell
1,542,981
-31,867
-2% -$4.19M 0.06% 284
2023
Q3
$192M Sell
1,574,848
-51,573
-3% -$6.87M 0.06% 280
2023
Q2
$229M Buy
1,626,421
+876
+0.1% +$121K 0.06% 253
2023
Q1
$230M Buy
1,625,545
+1,384,362
+574% +$198M 0.07% 249
2022
Q4
$37.7M Sell
241,183
-866
-0.4% -$124K 0.01% 788
2022
Q3
$29.7M Sell
242,049
-67,977
-22% -$8.95M 0.01% 872
2022
Q2
$41.2M Sell
310,026
-60,874
-16% -$8.29M 0.01% 758
2022
Q1
$50.8M Buy
370,900
+60,549
+20% +$8.44M 0.01% 774
2021
Q4
$53.7M Buy
310,351
+24,603
+9% +$3.74M 0.01% 748
2021
Q3
$41.5M Sell
285,748
-17,562
-6% -$2.57M 0.01% 1183
2021
Q2
$40M Buy
303,310
+8,902
+3% +$1.17M 0.01% 1215
2021
Q1
$37.8M Sell
294,408
-97,949
-25% -$12.1M 0.01% 1213
2020
Q4
$46.8M Buy
392,357
+24,428
+7% +$2.98M 0.01% 1030
2020
Q3
$42.1M Buy
367,929
+27,247
+8% +$3.22M 0.01% 961
2020
Q2
$38.8M Sell
340,682
-41,022
-11% -$4.35M 0.01% 985
2020
Q1
$30.7M Sell
381,704
-54,202
-12% -$5.61M 0.01% 1011
2019
Q4
$46.5M Sell
435,906
-28,968
-6% -$3.02M 0.01% 968
2019
Q3
$49.8M Sell
464,874
-46,185
-9% -$4.74M 0.01% 916
2019
Q2
$52M Sell
511,059
-15,861
-3% -$1.52M 0.01% 894
2019
Q1
$47.4M Sell
526,920
-747,811
-59% -$64.8M 0.01% 917
2018
Q4
$106M Sell
1,274,731
-22,122
-2% -$2.07M 0.04% 484
2018
Q3
$140M Sell
1,296,853
-67,274
-5% -$7.38M 0.04% 463
2018
Q2
$150M Sell
1,364,127
-207,683
-13% -$21.6M 0.04% 428
2018
Q1
$158M Buy
1,571,810
+7,141
+0.5% +$731K 0.05% 401
2017
Q4
$154M Buy
1,564,669
+9,640
+0.6% +$914K 0.04% 414
2017
Q3
$146M Buy
1,555,029
+60,793
+4% +$6.45M 0.05% 426
2017
Q2
$166M Sell
1,494,236
-4,500
-0.3% -$476K 0.05% 365
2017
Q1
$147M Buy
1,498,736
+28,371
+2% +$2.7M 0.05% 398
2016
Q4
$135M Buy
1,470,365
+93,884
+7% +$8.09M 0.05% 404
2016
Q3
$116M Sell
1,376,481
-32,671
-2% -$2.74M 0.04% 457
2016
Q2
$115M Sell
1,409,152
-160,077
-10% -$12.2M 0.04% 436
2016
Q1
$112M Buy
1,569,229
+50,322
+3% +$3.37M 0.04% 429
2015
Q4
$108M Sell
1,518,907
-45,130
-3% -$3.03M 0.04% 448
2015
Q3
$96.1M Sell
1,564,037
-514,083
-25% -$35.9M 0.04% 475
2015
Q2
$151M Sell
2,078,120
-23,974
-1% -$1.77M 0.06% 366
2015
Q1
$162M Buy
2,102,094
+597,238
+40% +$42.8M 0.06% 342
2014
Q4
$101M Buy
1,504,856
+202,665
+16% +$12.8M 0.04% 461
2014
Q3
$79M Sell
1,302,191
-2,260
-0.2% -$139K 0.03% 535
2014
Q2
$76.6M Buy
1,304,451
+59,995
+5% +$3.51M 0.03% 587
2014
Q1
$72.1M Buy
1,244,456
+795,006
+177% +$42.6M 0.03% 592
2013
Q4
$24.1M Buy
449,450
+137,872
+44% +$8.18M 0.01% 1128
2013
Q3
$19.3M Buy
311,578
+2,865
+0.9% +$171K 0.01% 1224
2013
Q2
$18.7M Buy
+308,713
New +$18.4M 0.01% 1186

Other funds holding DGX

Wells Fargo's DGX Position: Q1 2026 in Review

Wells Fargo reduced its Quest Diagnostics (DGX) stake by 0.36% in Q1 2026, selling an estimated $1.23M and leaving 1,762,769 shares worth $345M. The position accounts for 0.07% of the portfolio, ranked #259.

Wells Fargo first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Wells Fargo held 1,762,769 shares of Quest Diagnostics worth $345M as of Q1 2026.
  • Wells Fargo sold 6,324 Quest Diagnostics shares in Q1 2026, an estimated $1.23M.
  • Quest Diagnostics made up 0.07% of Wells Fargo's portfolio in Q1 2026, its #259 holding.
  • Wells Fargo first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.